Hisense Medical's First 4K Fluorescence Endoscope Receives NMPA Approval

A New Addition to the Domestic Medical Endoscopy Field. Recently, Hisense Medical’s first self-developed 4K fluorescence endoscope obtained a Class II medical device registration certificate issued by the National Medical Products Administration (NMPA), marking Hisense Medical’s strategic entry into the high-end 4K fluorescence medical endoscopy sector. As an innovative achievement in industrial expansion within the minimally invasive surgery field, the Hisense 4K fluorescence endoscope will integrate with existing smart operating room total solutions and endoscopic displays to form a comprehensive minimally invasive surgery solution.

Minimally invasive surgery is becoming increasingly prevalent due to its advantages, including small incisions, minimal trauma, and rapid recovery. Endoscopes, typically used in conjunction with minimally invasive surgical instruments and equipment, provide surgeons with clearer and more precise visualization. Driven by clinical demand, technological innovation, and the accelerating pace of domestic production, 4K fluorescence endoscopy has emerged as a major trend in the development of minimally invasive surgical techniques.

Compared with traditional medical endoscopes, the Hisense 4K fluorescence endoscope, when used in conjunction with the fluorescent contrast agent indocyanine green (ICG), provides real-time visible light and near-infrared fluorescence imaging for endoscopic surgeries. It is suitable for minimally invasive surgical procedures with high application volumes, such as laparoscopy, urological endoscopy, and hysteroscopy.

Hisense 4K Fluorescence Endoscope boasts advantages such as high-precision image registration, excellent fluorescence sensitivity, and leading-edge low-latency imaging, heralding an innovative revolution in minimally invasive surgery. It is reported that these three core technologies have reached industry-leading levels and patent applications for all of them have been filed.

In terms of image registration, the product precisely fuses fluorescence and white-light images, providing physicians with more accurate fluorescence-assisted localization to facilitate precise observation and manipulation of lesions. Regarding fluorescence sensitivity, it enables visualization even under weak fluorescence conditions, assisting physicians in more thoroughly localizing and identifying lesion areas, thereby reducing surgical risks. Leveraging low-latency imaging technology, innovative solutions achieve "hand-eye synchronization" for physicians, enhancing surgical comfort. As a future development direction, endoscopic intelligence stands out as a major highlight; the product supports various surgical assistance technologies, such as Hisense ultrasound and intelligent surgical navigation systems, while enabling fused multi-image display on a single screen to help physicians improve surgical efficiency.

As high-end medical devices, medical endoscopes are facing increasingly fierce competition in the Chinese market. In recent years, domestic endoscope manufacturers have actively participated in this sector, injecting new momentum into the innovation and development of minimally invasive surgery. As a Chinese medical equipment manufacturer, Hisense Medical is strategically expanding its presence in the field of minimally invasive surgery. The Hisense 4K Fluorescence Endoscope, as a key component of this strategy, will help build a more competitive product portfolio and enhance the brand’s influence in the high-end medical endoscopy segment. This strategic move will provide physicians and patients with more advanced and reliable surgical equipment, drive progress in the healthcare industry, and contribute to patients’ health and well-being.